Risk stratification of intermediate-risk acute myeloid leukemia: integrative analysis of a multitude of gene mutation and gene expression markersROCKOVA, Veronika; ABBAS, Saman; WOUTERS, Bas J et al.Blood. 2011, Vol 118, Num 4, pp 1069-1076, issn 0006-4971, 8 p.Article

Deregulated Expression of EVI1 Defines a Poor Prognostic Subset of MLL-Rearranged Acute Myeloid Leukemias: A Study of the German-Austrian Acute Myeloid Leukemia Study Group and the Dutch-Belgian-Swiss HOVON/SAKK Cooperative GroupGRÖSCHEL, Stefan; SCHLENK, Richard F; GERMING, Ulrich et al.Journal of clinical oncology. 2013, Vol 31, Num 1, pp 95-103, issn 0732-183X, 9 p.Article

Mutant DNMT3A: a marker of poor prognosis in acute myeloid leukemiaTIBURCIO RIBEIRO, Ana Flávia; PRATCORONA, Marta; VALK, Peter J. M et al.Blood. 2012, Vol 119, Num 24, pp 5824-5831, issn 0006-4971, 8 p.Article